Brian Velasco
Papers
2
Total Citations
28
H-Index
2
About
Brian Velasco is a leading figure in preclinical imaging, whose work bridges a critical gap between clinical diagnostic tools and laboratory animal models. His primary research focuses on the development and validation of multi-modal imaging systems, particularly for noninvasive assessment of liver disease and cancer. Velasco’s major contribution is the creation of a robotic shear wave elastography (SWE) system, a groundbreaking adaptation of a widely used clinical technology for murine models. This innovation allows researchers to noninvasively stage liver fibrosis, a key endpoint in drug development, with high precision—a capability previously unavailable to preclinical scientists. His work on this system (16 citations) has opened new avenues for longitudinal studies of disease progression. Velasco is also recognized for his comprehensive validation of a combined ultrasound and bioluminescence imaging platform against the gold standard of magnetic resonance imaging in orthotopic pancreatic tumor models (12 citations). This achievement demonstrated that deep-tissue, orthotopic tumors can be accurately monitored over time, addressing a major hurdle in cancer research. By providing robust, quantitative imaging solutions, Velasco is empowering researchers to translate preclinical findings more effectively, making his work indispensable for the next generation of therapeutic development.
Research Focus
Key Achievements
Top Papers
- 1
- 2